UPDATED Apr 25, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MYGN | US$17.98 | -2.9% | -15.1% | US$1.6b | US$24.08 | PS2.2x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
BVS | US$4.07 | -10.5% | 303.0% | US$323.5m | US$8.00 | PB1.5x | E54.7% | n/a | Healthcare | ||
LXEH | US$0.43 | 5.4% | -54.3% | US$1.4m | n/a | PB0.04x | n/a | n/a | Consumer Services | ||
UNIF | US$6.40 | -6.7% | -41.7% | US$35.1m | n/a | PB0.5x | n/a | 12.5% | Banks | ||
UPLD | US$2.16 | -6.9% | -37.2% | US$60.2m | US$4.67 | PB0.5x | E80.5% | n/a | Software | ||
CPIX | US$1.70 | 3.0% | -1.2% | US$24.1m | n/a | PB0.8x | n/a | n/a | Pharmaceuticals & Biotech | ||
SMLR | US$25.91 | 1.8% | -2.2% | US$182.2m | US$65.00 | PE8.9x | n/a | n/a | Healthcare | ||
AMC | US$3.28 | 12.3% | -93.1% | US$906.6m | US$4.62 | PE-2.3x | E47.9% | 0% | Media | ||
MOMO | US$5.72 | 0.7% | -26.5% | US$1.1b | US$9.07 | PE4x | E-3.7% | 9.4% | Media | ||
UCAS.U | US$0.49 | 0% | -59.0% | US$2.7m | n/a | PS1.1x | n/a | n/a | Real Estate Management and Development | ||
EBIX.Q | US$0.54 | -14.3% | -96.7% | US$16.7m | n/a | PE3.4x | n/a | 0% | Software | ||
BCBP | US$9.44 | -0.8% | -18.1% | US$160.0m | US$12.50 | PB0.5x | E0.7% | 6.8% | Banks | ||
W | US$50.95 | -6.9% | 39.7% | US$6.1b | US$70.22 | PE-8.3x | E52.7% | n/a | Retail | ||
AMCX | US$11.33 | 6.9% | -34.8% | US$493.6m | US$12.83 | PE2.3x | E-5.6% | n/a | Media | ||
ZFOX | US$1.14 | 0% | 8.6% | US$142.3m | n/a | PB1x | S-4.6% | n/a | Software | ||
CATY | US$34.96 | 0.9% | 12.6% | US$2.5b | US$39.50 | PB0.9x | E-4.9% | 3.9% | Banks | ||
NHHS | US$1.05 | 0% | n/a | US$195.0m | n/a | PB1.5x | n/a | 0% | Real Estate |